On subgroup analysis, NAFLD and MAFLD participants with normal ALT were at a heightened risk of 3-point MACE, whilst there was no significant difference for 3-point MACE in those with elevated ALT. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.